The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is… read more.
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the… read more.
Heart disease remains the leading cause of death worldwide, according to the American Heart Association’s Heart Disease and Stroke Statistics — 2021 Update,
Interview and article by Christine Clark. Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic… read more.
Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.
Diets rich in healthy and plant-based foods encourages the presence of gut microbes that are linked to a lower risk of common illnesses including heart disease, research has… read more.
Interview and article by Christine Clark Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19…. read more.
Interview and article by Christine Clark. Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for… read more.
Interview and article by Christine Clark. IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin… read more.
Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung over the course of hours.
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.
Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
